Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Biote (BTMD) Shares Outstanding (2021 - 2025)

Biote has reported Shares Outstanding over the past 5 years, most recently at $30.7 million for Q4 2025.

  • Quarterly results put Shares Outstanding at $30.7 million for Q4 2025, up 488.19% from a year ago — trailing twelve months through Dec 2025 was $30.7 million (up 488.19% YoY), and the annual figure for FY2025 was $30.7 million, up 488.19%.
  • Shares Outstanding for Q4 2025 was $32.3 million at Biote, up from $5.2 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BTMD hit a ceiling of $48.6 million in Q2 2022 and a floor of $982800.0 in Q2 2021.
  • Median Shares Outstanding over the past 5 years was $31.3 million (2024), compared with a mean of $24.0 million.
  • Biggest five-year swings in Shares Outstanding: surged 4841.58% in 2022 and later plummeted 85.0% in 2024.
  • Biote's Shares Outstanding stood at $982800.0 in 2021, then surged by 4841.58% to $48.6 million in 2022, then tumbled by 40.66% to $28.8 million in 2023, then crashed by 81.88% to $5.2 million in 2024, then surged by 488.19% to $30.7 million in 2025.
  • The last three reported values for Shares Outstanding were $30.7 million (Q4 2025), $30.7 million (Q3 2025), and $31.7 million (Q2 2025) per Business Quant data.